Search details
1.
Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes.
Br J Cancer
; 128(1): 91-101, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36323879
2.
Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort.
BMC Cancer
; 23(1): 60, 2023 Jan 18.
Article
in English
| MEDLINE | ID: mdl-36650482
3.
Fifty-year forecasts of daily smoking prevalence: can Australia reach 5% by 2030?
Tob Control
; 2023 May 22.
Article
in English
| MEDLINE | ID: mdl-37217260
4.
Large-Scale Population-Based Surveys Linked to Administrative Health Databases as a Source of Data on Health Utilities in Australia.
Value Health
; 25(9): 1634-1643, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35527166
5.
Cancer incidence and cancer death in relation to tobacco smoking in a population-based Australian cohort study.
Int J Cancer
; 149(5): 1076-1088, 2021 09 01.
Article
in English
| MEDLINE | ID: mdl-34015143
6.
Impact of weighting on the association between sociodemographic characteristics, health behaviours and cancer, cardiovascular and all-cause mortality in the Australian 45 and Up Study.
Cancer Epidemiol
; 90: 102567, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38603997
7.
A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis.
Breast
; 67: 78-88, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36646004
8.
Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia.
Pharmacoeconomics
; 41(11): 1525-1537, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37357233
9.
Economic impact of using risk models for eligibility selection to the International lung screening Trial.
Lung Cancer
; 176: 38-45, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36592498
10.
Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods.
Lung Cancer
; 166: 122-131, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35276628
11.
Capacity of the 45 and Up Study to mobilise evidence-based improvements in cancer control: lung cancer case study.
Public Health Res Pract
; 32(4)2022 Dec 13.
Article
in English
| MEDLINE | ID: mdl-36509689
12.
Evaluating Prognostic Factors for Sex Differences in Lung Cancer Survival: Findings From a Large Australian Cohort.
J Thorac Oncol
; 17(5): 688-699, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35124253
13.
Health utilities for participants in a population-based sample who meet eligibility criteria for lung cancer screening.
Lung Cancer
; 169: 47-54, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35643060
14.
Lung cancer treatment patterns and factors relating to systemic therapy use in Australia.
Asia Pac J Clin Oncol
; 18(5): e235-e246, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-34250751
15.
Health services costs for lung cancer care in Australia: Estimates from the 45 and Up Study.
PLoS One
; 15(8): e0238018, 2020.
Article
in English
| MEDLINE | ID: mdl-32866213
Results
1 -
15
de 15
1
Next >
>>